Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, 610041, China.
Int J Colorectal Dis. 2021 Jul;36(7):1407-1419. doi: 10.1007/s00384-021-03918-6. Epub 2021 Apr 7.
To compare single-incision laparoscopic surgery (SILS) and multiport laparoscopic surgery (MLS) for colorectal cancer in terms of short- and long-term outcomes.
A systematic literature search was performed in PubMed, Web of Science, and Embase. Randomized controlled trials (RCTs) and propensity-score matched (PSM) studies comparing SILS and MLS for colorectal cancer were enrolled. Outcomes of interests included intraoperative, postoperative, pathological, and survival outcomes.
Sixteen studies (6 RCTs and 10 PSM studies) published between 2012 and 2020 with a total of 2425 patients were enrolled. Compared with MLS, SILS was associated with less postoperative pain at postoperative day (POD) 1 (P = 0.02, MWD = -0.73, 95%CI: -1.37, -0.09) and POD2 (P < 0.001, MWD= -1.10, 95%CI: -1.45, -0.74) and shorter length of total incision length (P < 0.001, MWD = -3.31, 95%CI: -3.95, -2.67). No differences were observed in terms of operative time, blood loss, intraoperative and postoperative complications, incision hernia, and pathological or survival outcomes between SILS and MLS. Subgroup analysis for right-sided colon cancer, sigmoid colon cancer, and rectosigmoid colon cancer showed that the SILS group was only associated with less postoperative pain and shorter total incision length. The surgical and pathological outcomes were comparable between SILS and MLS.
SILS is a beneficial alternative to MLS in select colorectal cancer patients, especially for right-sided colon cancer, sigmoid colon cancer, and rectosigmoid cancer, with better cosmetic effects and less postoperative pain. Simultaneously, SILS does not compromise intraoperative and postoperative complications, surgical quality, or long-term outcomes.
比较单切口腹腔镜手术(SILS)和多孔腹腔镜手术(MLS)治疗结直肠癌的短期和长期结果。
在 PubMed、Web of Science 和 Embase 中进行系统文献检索。纳入比较 SILS 和 MLS 治疗结直肠癌的随机对照试验(RCT)和倾向评分匹配(PSM)研究。感兴趣的结局包括术中、术后、病理和生存结局。
纳入了 2012 年至 2020 年期间发表的 16 项研究(6 项 RCT 和 10 项 PSM 研究),共纳入 2425 例患者。与 MLS 相比,SILS 术后第 1 天(P = 0.02,MWD = -0.73,95%CI:-1.37,-0.09)和第 2 天(P < 0.001,MWD = -1.10,95%CI:-1.45,-0.74)的术后疼痛较轻,总切口长度较短(P < 0.001,MWD = -3.31,95%CI:-3.95,-2.67)。SILS 和 MLS 之间在手术时间、出血量、术中及术后并发症、切口疝以及病理或生存结局方面无差异。对于右半结肠癌、乙状结肠癌和直肠乙状结肠癌,亚组分析显示 SILS 组仅与术后疼痛较轻和总切口长度较短相关。SILS 和 MLS 在手术和病理结果方面具有可比性。
SILS 是结直肠癌患者的一种有益选择,特别是对于右半结肠癌、乙状结肠癌和直肠乙状结肠癌,具有更好的美容效果和较轻的术后疼痛。同时,SILS 并不影响术中及术后并发症、手术质量或长期结局。